What is he best known for?
The fields of study he is best known for:
- Cancer
- Immune system
- Cytokine
Viktor Umansky mainly investigates Myeloid-derived Suppressor Cell, Immunology, Tumor progression, Tumor microenvironment and Melanoma.
His Myeloid-derived Suppressor Cell research is multidisciplinary, incorporating elements of Cytotoxic T cell, T cell, Cancer research and Immunosuppression.
His Cancer research study incorporates themes from Cancer cell and Interleukin 21.
His Immunology study combines topics from a wide range of disciplines, such as Gemcitabine, Pancreatic cancer and Transforming growth factor.
Viktor Umansky has researched Tumor progression in several fields, including Chemokine, Immune system and Stromal cell.
The various areas that he examines in his Tumor microenvironment study include Carcinogenesis, Survival rate, Paclitaxel, Pharmacology and Immunotherapy.
His most cited work include:
- Bone marrow as a priming site for T-cell responses to blood-borne antigen (276 citations)
- NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo (258 citations)
- Tumor-Infiltrating Monocytic Myeloid-Derived Suppressor Cells Mediate CCR5-Dependent Recruitment of Regulatory T Cells Favoring Tumor Growth (235 citations)
What are the main themes of his work throughout his whole career to date?
Cancer research, Immunology, Melanoma, Immune system and Tumor microenvironment are his primary areas of study.
His Cancer research study combines topics in areas such as Cancer, Metastasis, Immunotherapy and CD8.
Viktor Umansky combines subjects such as Disease, Myeloid-derived Suppressor Cell and Cell biology with his study of Immunology.
The Myeloid-derived Suppressor Cell study combines topics in areas such as Immunosuppression, Paclitaxel, Immune tolerance, Chemokine and Tumor progression.
His Melanoma research incorporates themes from Oncology, Skin cancer, Downregulation and upregulation, Pathology and Genetically modified mouse.
His Immune system research includes themes of Pancreatic cancer, Myeloid, Internal medicine, Antigen and Cytotoxic T cell.
He most often published in these fields:
- Cancer research (80.33%)
- Immunology (57.38%)
- Melanoma (59.02%)
What were the highlights of his more recent work (between 2018-2021)?
- Cancer research (80.33%)
- Melanoma (59.02%)
- Immune system (48.63%)
In recent papers he was focusing on the following fields of study:
Viktor Umansky spends much of his time researching Cancer research, Melanoma, Immune system, Immunotherapy and Myeloid-derived Suppressor Cell.
His Cancer research study combines topics from a wide range of disciplines, such as Cancer, Tumor progression and CD8.
Viktor Umansky has included themes like Histone methyltransferase, Skin cancer, Reprogramming, MEK inhibitor and Targeted therapy in his Melanoma study.
His studies in Immune system integrate themes in fields like Myeloid and Antigen.
His work deals with themes such as Biomarker, Adjuvant and Metastasis, which intersect with Immunotherapy.
His Myeloid-derived Suppressor Cell study integrates concerns from other disciplines, such as Inflammation and Immunology.
Between 2018 and 2021, his most popular works were:
- Deciphering myeloid-derived suppressor cells: isolation and markers in humans, mice and non-human primates (66 citations)
- Deciphering myeloid-derived suppressor cells: isolation and markers in humans, mice and non-human primates (66 citations)
- SOX2 in development and cancer biology. (33 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Immune system
- Cytokine
His main research concerns Cancer research, Immune system, Melanoma, Cancer and Immunotherapy.
Many of his studies involve connections with topics such as Tumor progression and Cancer research.
His study in Immune system is interdisciplinary in nature, drawing from both Myeloid and Myeloid-derived Suppressor Cell.
His Myeloid-derived Suppressor Cell research incorporates themes from Stromal cell, Inflammation, Immunosuppression, Immunology and Disease.
He interconnects Phenotypic switching, Histone H3, Reprogramming and Immune checkpoint inhibitors in the investigation of issues within Melanoma.
His work in Immunotherapy tackles topics such as Tumor microenvironment which are related to areas like Adjuvant, S100A8, Metastasis, Biomarker and Cytotoxic T cell.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
